Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal ADRBK1 Primary Antibody for IHC (p), WB - ABIN1882061
Eichmann, Lorenz, Hoffmann, Brockmann, Krasel, Lohse, Quitterer: The amino-terminal domain of G-protein-coupled receptor kinase 2 is a regulatory Gbeta gamma binding site. in The Journal of biological chemistry 2003
Show all 6 Pubmed References
Human Monoclonal ADRBK1 Primary Antibody for ICC, IHC - ABIN969178
Chen, Long, Wu, Jiang, Ma: EGF transregulates opioid receptors through EGFR-mediated GRK2 phosphorylation and activation. in Molecular biology of the cell 2008
Show all 2 Pubmed References
Human Polyclonal ADRBK1 Primary Antibody for ELISA, WB - ABIN251302
Iaccarino, Barbato, Cipolletta, De Amicis, Margulies, Leosco, Trimarco, Koch: Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. in European heart journal 2005
Human Monoclonal ADRBK1 Primary Antibody for IF, IHC - ABIN966226
Sterne-Marr, Leahey, Bresee, Dickson, Ho, Ragusa, Donnelly, Amie, Krywy, Brookins-Danz, Orakwue, Carr, Yoshino-Koh, Li, Tesmer: GRK2 activation by receptors: role of the kinase large lobe and carboxyl-terminal tail. in Biochemistry 2009
Show all 2 Pubmed References
Cow (Bovine) Monoclonal ADRBK1 Primary Antibody for IHC (fro), IF - ABIN534096
Pitcher, Freedman, Lefkowitz: G protein-coupled receptor kinases. in Annual review of biochemistry 1998
Show all 3 Pubmed References
Enhanced GRK2 expression triggers cardiac hypertrophy by GRK2-PI3Kgamma (show PIK3CG Antibodies) mediated Akt (show AKT1 Antibodies) phosphorylation and subsequent inactivation of GSK3beta (show GSK3b Antibodies).
Grk2 rescuing activity requires the integrity of domains essential for its interaction with GPCRs, we speculate that Grk2 may regulate Hh pathway activity by downregulation of a GPCR.
The main novelty presented here is to show that septic shock induces cardiac hyporesponsiveness to isoproterenol by a mechanism dependent on nitric oxide and mediated by G protein-coupled receptor (show GPR34 Antibodies) kinase isoform 2. Therefore, G protein-coupled receptor (show GPR34 Antibodies) kinase isoform 2 inhibition may be a potential therapeutic target in sepsis-induced cardiac dysfunction.
Data, including data from studies in heterozygous knockout mice, suggest that Grk2 is involved in TNFalpha (show TNF Antibodies)-induced wound healing in epithelial cells of the colon; Grk2 appears to inhibit TNFalpha (show TNF Antibodies)-induced apoptosis; Grk2 inhibits TNFalpha (show TNF Antibodies)-induced ERK (show EPHB2 Antibodies) activation by inhibiting generation of reactive oxygen species. Homozygous knockout of Grk2 is embryonically lethal in mice.
GRK2 upregulation causes kappa-opioid receptor (show OPRK1 Antibodies) desensitization in diabetic heart
study provides the first insights into the role of GRK2 in skeletal muscle physiology and points to a role for GRK2 as a modulator of contractile properties in skeletal muscle as well as beta2AR (show ADRB2 Antibodies)-induced hypertrophy.
GRK2 loss confers a protective advantage over control mice after myocardial ischemia/reperfusion injury. Fibroblast GRK2 knockout mice presented with decreased infarct size and preserved cardiac function 24 hours post ischemia/reperfusion. They had decreased fibrosis and fibrotic gene expression. These protective effects correlated with decreased infiltration of neutrophils to the ischemia site and decreased TNF-alpha (show TNF Antibodies).
this study shows that astragaloside IV alleviates E. coli-caused peritonitis through modulating GRK2-CXCR2 (show CXCR2 Antibodies) signal in neutrophils
GRK2 down-regulation is cardioprotective during diet-induced obesity, reinforcing the protective effect of maintaining low levels of GRK2 under nutritional stress, and showing a role for this kinase in obesity-induced cardiac remodeling and steatosis.
The betaARKrgs peptide, but not endogenous GRK2, interacted with Galpha(q (show GNAQ Antibodies)) and interfered with signaling through this G protein. These data support the development of GRK2-based therapeutic approaches to prevent hypertrophy and heart failure.
The PIP2-induced orientation of the GRK2-Gbeta1gamma2 complex is therefore most likely caused by specific interactions between PIP2 and the GRK2 PH domain.
Mitochondrial-targeted GRK2 is essential for prodeath signaling occurring after oxidative stress in myocytes and assigning a novel role for this GRK (show GRK4 Antibodies).
Indicate that the anti-proliferative function of elevated GRK2 in hepatocellular carcinoma is associated with delayed cell cycle progression and is GRK2 kinase activity-dependent.
G alpha q/11 interacts with this protein. A novel surface on a regulator of G protein signals a homology domain for binding G alpha subunits (GRK2 kinase}
determined the crystallographic structure of GRK2 in complex with G protein beta1gamma2 subunits.
intramolecular interactions could play a role in regulating G protein-coupled receptor kinase 2 (GRK2).
epithelial Na-channels are maintained in the active state by Grk2; Grk2 phosphorylates the C terminus of the channel beta subunit (show POLG Antibodies) and renders the channels insensitive to inhibition by Nedd4-2 (show NEDD4L Antibodies).
Crystallographic and biochemical studies provide evidence that the major domain interfaces of G protein-coupled beta adrenergic receptor kinase 1 (GRK2) remain associated during Gbetagamma binding and activation of GRK2.
Resultrs suggest that activated platelet-derived growth factor receptor-beta (show PDGFRB Antibodies) (PDGFRbeta) phosphorylates GRK2 tyrosyl residues and thereby activates GRK2, which then serine-phosphorylates and desensitizes the PDGFRbeta.
GRK2-as5 has a role in membrane trafficking of the mu-opioid receptor (show OPRM1 Antibodies)
Low grk2 expression is associated with lung metastasis in gastric cancer.
Lowering the level of cellular FLNA (show FLNA Antibodies) caused an elevation in RalA (show rala Antibodies) activity and resulted in selective interference with the normal intracellular trafficking and signaling of D2R (show DRD2 Antibodies) through GRK2.
Results demonstrate that GPR3 (show GPR3 Antibodies) signals at the plasma membrane and can be silenced by GRK2/beta-arrestin overexpression. These results also strongly implicate the serine and/or threonine residues in the third intracellular loop in the regulation of GPR3 (show GPR3 Antibodies) activity.
GRK2 is negatively related to IGF1R (show IGF1R Antibodies) and IGF1R (show IGF1R Antibodies), but not GRK2, was associated with the tumour-node-metastasis stage and overall and disease-free survival in hepatocellular carcinoma.
The tyrosine-phosphorylated GRK2 mediates this inhibition by acting on the second intracellular loop of D3R.
GRK2 is overexpressed in pancreatic cancer, and might serve as a potential indicator of unfavorable prognosis.
Data, including data from studies in heterozygous knockout mice, suggest that GRK2 is involved in TNFalpha (show TNF Antibodies)-induced wound healing in epithelial cells of the colon; GRK2 appears to inhibit TNFalpha (show TNF Antibodies)-induced apoptosis; GRK2 inhibits TNFalpha (show TNF Antibodies)-induced ERK (show EPHB2 Antibodies) activation by inhibiting generation of reactive oxygen species. Homozygous knockout of GRK2 is embryonically lethal in mice.
The dominant model (CC vs. CT+TT) of rs1894111 polymorphism in the ADRBK1 gene might be associated with low-renin hypertension in Han Chinese.
Our data suggest that GRK2 acts as an important onco-modulator by strengthening the functionality of key players in breast tumorigenesis such as HDAC6 (show HDAC6 Antibodies) and Pin1 (show PIN1 Antibodies).
GRK2 may inhibit IGF1 (show IGF1 Antibodies)-induced human hepatocellular carcinoma cell growth and migration through downregulation of EGR1 (show EGR1 Antibodies).
The product of this gene phosphorylates the beta-2-adrenergic receptor and appears to mediate agonist-specific desensitization observed at high agonist concentrations. This protein is an ubiquitous cytosolic enzyme that specifically phosphorylates the activated form of the beta-adrenergic and related G-protein-coupled receptors. Abnormal coupling of beta-adrenergic receptor to G protein is involved in the pathogenesis of the failing heart.
beta-adrenergic receptor kinase 1
, adrenergic, beta, receptor kinase 1
, G-protein-coupled receptor kinase 2
, beta ARK
, beta ARK1
, beta-AR kinase-1
, beta-adrenergic receptor kinase-1
, G-protein coupled receptor kinase 2
, adrenergic receptor kinase, beta 1
, beta-adrenergic receptor kinase 1 beta ARK1